Literature DB >> 26924091

Alcoholic Liver Disease in Asia, Europe, and North America.

Suthat Liangpunsakul1, Paul Haber2, Geoffrey W McCaughan3.   

Abstract

Alcoholic liver diseases comprise a spectrum of clinical disorders and changes in liver tissue that can be detected by pathology analysis. These range from steatosis to more severe signs and symptoms of liver disease associated with inflammation, such as those observed in patients with alcoholic hepatitis or cirrhosis. Although the relationship between alcohol consumption and liver disease is well established, severe alcohol-related morbidities develop in only a minority of people who consume alcohol in excess. Inter-individual differences in susceptibility to the toxic effects of alcohol have been studied extensively-they include pattern of alcohol consumption, sex, environmental factors (such as diet), and genetic factors, which vary widely among different parts of the world. Alcoholic liver disease is becoming more common in many parts of Asia, but is decreasing in Western Europe. Treatment approaches, including availability of medications, models of care, and approach to transplantation, differ among regions.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic Liver Disease; Asia; Clinical Profiles; Europe; North America

Mesh:

Year:  2016        PMID: 26924091      PMCID: PMC4887319          DOI: 10.1053/j.gastro.2016.02.043

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  105 in total

1.  Establishing rates of binge drinking in the UK: anomalies in the data.

Authors:  John McAlaney; John McMahon
Journal:  Alcohol Alcohol       Date:  2006-04-19       Impact factor: 2.826

2.  Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population.

Authors:  Atanu Kumar Dutta
Journal:  Ann Hepatol       Date:  2013 Nov-Dec       Impact factor: 2.400

Review 3.  Pharmacotherapy for alcoholic patients with alcoholic liver disease.

Authors:  Cynthia L Vuittonet; Michael Halse; Lorenzo Leggio; Samuel B Fricchione; Michael Brickley; Carolina L Haass-Koffler; Tonya Tavares; Robert M Swift; George A Kenna
Journal:  Am J Health Syst Pharm       Date:  2014-08-01       Impact factor: 2.637

4.  CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.

Authors:  You-Chen Chao; Heng-Cheng Chu; Wei-Kuo Chang; Hsin-Hung Huang; Tsai-Yuan Hsieh
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  Polymorphisms in the interleukin-10 gene promoter and the risk of alcoholism and alcoholic liver disease in Caucasian Spaniard men.

Authors:  Teresa Auguet; Francesc Vidal; Montserrat Broch; Montserrat Olona; Carmen Aguilar; Beatriz Morancho; Miguel López-Dupla; Joan-Carles Quer; Joan-Josep Sirvent; Cristóbal Richart
Journal:  Alcohol       Date:  2010-05-31       Impact factor: 2.405

Review 6.  Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China.

Authors:  Qing Li; Thomas F Babor; Donald Zeigler; Ziming Xuan; Donald Morisky; Melbourne F Hovell; Toben F Nelson; Weixing Shen; Bing Li
Journal:  Addiction       Date:  2015-01       Impact factor: 6.526

7.  Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.

Authors:  Virendra Singh; Arun K Sharma; R Lakshmi Narasimhan; Ashish Bhalla; Navneet Sharma; Ratiram Sharma
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

8.  Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.

Authors:  Carole L Hart; David S Morrison; G David Batty; Richard J Mitchell; George Davey Smith
Journal:  BMJ       Date:  2010-03-11

Review 9.  The current situation of treatment systems for alcoholism in Korea.

Authors:  Jee Wook Kim; Boung Chul Lee; Tae-Cheon Kang; Ihn-Geun Choi
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

10.  Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey.

Authors:  Michael R Phillips; Jingxuan Zhang; Qichang Shi; Zhiqiang Song; Zhijie Ding; Shutao Pang; Xianyun Li; Yali Zhang; Zhiqing Wang
Journal:  Lancet       Date:  2009-06-13       Impact factor: 79.321

View more
  54 in total

Review 1.  Alcohol-Associated Liver Disease: East Versus West.

Authors:  Phunchai Charatcharoenwitthaya; Suthat Liangpunsakul; Teerha Piratvisuth
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

2.  An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.

Authors:  Juan P Arab; Tejasav S Sehrawat; Douglas A Simonetto; Vikas K Verma; Dechun Feng; Tom Tang; Kevin Dreyer; Xiaoqiang Yan; William L Daley; Arun Sanyal; Naga Chalasani; Svetlana Radaeva; Liu Yang; Hugo Vargas; Mauricio Ibacache; Bin Gao; Gregory J Gores; Harmeet Malhi; Patrick S Kamath; Vijay H Shah
Journal:  Hepatology       Date:  2020-04-27       Impact factor: 17.425

3.  Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise.

Authors:  Jia Xiao; Fei Wang; Nai-Kei Wong; Yi Lv; Yingxia Liu; Jiajun Zhong; Shuaiyin Chen; Wei Li; Kazuo Koike; Xiaowei Liu; Hua Wang
Journal:  Gene Expr       Date:  2020-07-20

4.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

Review 5.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

6.  Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.

Authors:  Xiaojuan Chao; Shaogui Wang; Katrina Zhao; Yuan Li; Jessica A Williams; Tiangang Li; Hemantkumar Chavan; Partha Krishnamurthy; Xi C He; Linheng Li; Andrea Ballabio; Hong-Min Ni; Wen-Xing Ding
Journal:  Gastroenterology       Date:  2018-05-18       Impact factor: 22.682

7.  Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Authors:  Brian P Lee; Sumeyye Samur; Ozden O Dalgic; Emily D Bethea; Michael R Lucey; Ethan Weinberg; Christine Hsu; Mary E Rinella; Gene Y Im; Oren K Fix; George Therapondos; Hyosun Han; David W Victor; Michael D Voigt; Sheila Eswaran; Norah A Terrault; Jagpreet Chhatwal
Journal:  Gastroenterology       Date:  2019-04-15       Impact factor: 22.682

Review 8.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

9.  Microfluidic confinement enhances phenotype and function of hepatocyte spheroids.

Authors:  Jong Hoon Choi; Lorena Loarca; Jose M De Hoyos-Vega; Neda Dadgar; Kevin Loutherback; Vijay H Shah; Gulnaz Stybayeva; Alexander Revzin
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-22       Impact factor: 4.249

10.  Engineered Liver Tissue Culture in an In Vitro Tubular Perfusion System.

Authors:  Guang Yang; Bhushan Mahadik; Trevor Mollot; Julia Pinsky; Athenia Jones; Alexis Robinson; Daniel Najafali; Daniel Rivkin; Jenny Katsnelson; Charlotte Piard; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-11-24       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.